The EMBO Journal
 
Advanced search
Journal home
Current issue
Advance Online Publication
Web Focuses
Archive
Browse by subject
Free online sample issue
Aims and scope
Press releases
ToC by email
Authors & Referees
Guide for authors
Submit an Article
Guide for referees
Editorial Team, Senior Advisors and Advisory Editorial Board
Contact Editorial office
Customer services
Subscribe
Order sample copy
Purchase articles
Reprints and permissions
Contact NPG
Advertising
EMBO
www.embo.org
Article
Subject Categories: RNA | Molecular Biology of Disease
The EMBO Journal (2004) 23, 885–896, doi:10.1038/sj.emboj.7600054
Published online 12 February 2004
Dilated cardiomyopathy caused by tissue-specific ablation of SC35 in the heart
Jian-Hua Ding1, Xiangdong Xu1, Dongmei Yang2, Pao-Hsien Chu3, 4, Nancy D Dalton3, Zhen Ye1, Joanne M Yeakley1, 5, Heping Cheng2, Rui-Ping Xiao2, John Ross Jr3, Ju Chen3 and Xiang-Dong Fu1
1 Department of Cellular and Molecular Medicine, University of California at San Diego, La Jolla, CA, USA
2 Laboratory of Cardiovascular Science, Gerontology Research Center, NIA, NIH, Baltimore, MD, USA
3 Department of Medicine and Institute of Molecular Medicine, University of California at San Diego, La Jolla, CA, USA

To whom correspondence should be addressed
Xiang-Dong Fu, Department of Cellular and Molecular Medicine, University of California at San Diego, CMM(W) 231A, 9500 Gilman Drive, La Jolla, CA 92093-0651, USA. Tel.: +1 858 534 4937; Fax: +1 858 534 8549; E-mail: xdfu@ucsd.edu

4 Present address: The First Cardiovascular Department, Internal Medicine, Chang Gung Memorial Hospital, Taipei, Taiwan
5 Current address: Illumina, Inc., 9885 Towne Centre Drive, San Diego, CA 92121-1975, USA

Received 23 September 2003; Accepted 5 December 2003; Published online 12 February 2004.
Abstract
Many genetic diseases are caused by mutations in cis-acting splicing signals, but few are triggered by defective trans-acting splicing factors. Here we report that tissue-specific ablation of the splicing factor SC35 in the heart causes dilated cardiomyopathy (DCM). Although SC35 was deleted early in cardiogenesis by using the MLC-2v-Cre transgenic mouse, heart development appeared largely unaffected, with the DCM phenotype developing 3–5 weeks after birth and the mutant animals having a normal life span. This nonlethal phenotype allowed the identification of downregulated genes by microarray, one of which was the cardiac-specific ryanodine receptor 2. We showed that downregulation of this critical Ca2+ release channel preceded disease symptoms and that the mutant cardiomyocytes exhibited frequency-dependent excitation–contraction coupling defects. The implication of SC35 in heart disease agrees with a recently documented link of SC35 expression to heart failure and interference of splicing regulation during infection by myocarditis-causing viruses. These studies raise a new paradigm for the etiology of certain human heart diseases of genetic or environmental origin that may be triggered by dysfunction in RNA processing.
Keywords: heart disease, splicing regulation, SR proteins
Top

MORE ARTICLES LIKE THIS

Send to a friendEmail link to a friend
PDFDownload PDF
Full textFull text
Next article
Previous article
Table of contents
rights and permissionsRights and permissions
order commercial reprintsReprints
ToC alertRegister for table of contents by email
  Privacy policy Copyright © 2004 by the European Molecular Biology Organization